bazedoxifene

signal transducer and activator of transcription 3 ; Mus musculus







9 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33347820 Bazedoxifene exhibits anti-inflammation and anti-atherosclerotic effects via inhibition of IL-6/IL-6R/STAT3 signaling. 2021 Feb 15 2
2 34365219 Bazedoxifene inhibits sustained STAT3 activation and increases survival in GBM. 2021 Nov 7
3 35118141 IL-6/STAT3 Signaling Promotes Cardiac Dysfunction by Upregulating FUNDC1-Dependent Mitochondria-Associated Endoplasmic Reticulum Membranes Formation in Sepsis Mice. 2021 1
4 32164044 Inhibition of Interleukin-6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice. 2020 Apr 2
5 32362823 Bazedoxifene Attenuates Abdominal Aortic Aneurysm Formation via Downregulation of Interleukin-6/Glycoprotein 130/Signal Transducer and Activator of Transcription 3 Signaling Pathway in Apolipoprotein E-Knockout Mice. 2020 6
6 30648776 Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma. 2019 Mar 5
7 30852762 Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer. 2019 Jun 2
8 30885958 Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth. 2019 Apr 2
9 28672024 Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy. 2017 1